Publications
-
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
Oncogene 2021, 40(7):1284-1299 (doi: 10.1038/s41388-020-01603-6)
Go to publication
-
EGFR as a stable marker of prostate cancer dissemination to bones
British Journal of Cancer 2020, 123(12):1767-1774 (doi: 10.1038/s41416-020-01052-8)
Go to publication
-
NF-kappa B signalling-related signatures are connected with mesenchymal phenotype of circulating tumour cells in non-metastatic breast cancer
Cancers (Basel) 2019, 11(12):1961 (doi: 10.3390/cancers11121961)
Go to publication
-
Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
Oncotarget 2017, 8:106415-106428 (doi: 10.18632/oncotarget.22468)
Go to publication
-
Potential role of Jagged 1 in metastatic progression of human breast carcinomas
Clinical Chemistry 2016, 62(2):378-86 (doi: 10.1373/clinchem.2015.246686)
Go to publication
-
Circulating tumor cells in patients with testicular germ cell tumors
Clinical Cancer Research 2014, 20(14): 3830-3841 (doi: 10.1158/1078-0432.CCR-13-2819)
Go to publication
-
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Cancer & Metastasis Reviews 2012, 31(3-4): 673-687 (doi: 10.1007/s10555-012-9370-z)
Go to publication